Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH

Watchlist Manager
Reviva Pharmaceuticals Holdings, Inc. Logo
Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH
Watchlist
Price: 0.3213 USD -45.54% Market Closed
Market Cap: 37m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of RVPH.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RVPH Intrinsic Value
Not Available
Base Case Scenario
Compare RVPH to

Fundamental Analysis

Reviva Pharmaceuticals Holdings, Inc.
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RVPH?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Reviva Pharmaceuticals Holdings, Inc.

Current Assets 13.5m
Cash & Short-Term Investments 13.2m
Other Current Assets 329.6k
Non-Current Assets 819.8k
Other Non-Current Assets 819.8k
Current Liabilities 9.7m
Accounts Payable 5.4m
Accrued Liabilities 4.3m
Non-Current Liabilities 44.5k
Other Non-Current Liabilities 44.5k
Efficiency

Free Cash Flow Analysis
Reviva Pharmaceuticals Holdings, Inc.

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Reviva Pharmaceuticals Holdings, Inc.

Revenue
0 USD
Operating Expenses
-22.9m USD
Operating Income
-22.9m USD
Other Expenses
168.9k USD
Net Income
-22.8m USD
Fundamental Scores

RVPH Profitability Score
Profitability Due Diligence

Reviva Pharmaceuticals Holdings, Inc.'s profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
Exceptional ROE
ROE is Increasing
60/100
Profitability
Score

Reviva Pharmaceuticals Holdings, Inc.'s profitability score is 60/100. The higher the profitability score, the more profitable the company is.

RVPH Solvency Score
Solvency Due Diligence

Reviva Pharmaceuticals Holdings, Inc.'s solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
37/100
Solvency
Score

Reviva Pharmaceuticals Holdings, Inc.'s solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RVPH Price Targets Summary
Reviva Pharmaceuticals Holdings, Inc.

There are no price targets for RVPH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Reviva Pharmaceuticals Holdings, Inc.
does not pay dividends
Shareholder Yield

Current shareholder yield for RVPH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

RVPH Insider Trading
Buy and sell transactions by insiders